Wang Yifan, Wang Xinhuan, Chen Jun, Wallace Gordon, Gu Qi
Key Laboratory of Organ Regeneration and Reconstruction State Key Laboratory of Membrane Biology Institute of Zoology Beijing 100101 P. R. China.
University of Chinese Academy of Sciences Beijing 100049 P. R. China.
Small Sci. 2024 Sep 10;4(11):2400261. doi: 10.1002/smsc.202400261. eCollection 2024 Nov.
Cardiovascular disease has emerged as the leading cause of death worldwide. Since coronary arteries, carotid arteries, and other blood vessels are prone to narrowing, small-diameter artificial blood channels offer a crucial solution for restoring blood flow. Ideal grafts must emulate the structure of natural blood vessels, possess adequate mechanical strength, ensure long-term patency, and incorporate functional cells with minimal immunogenicity. Enhanced cell sources and engineering methods are vital for the creation of functional small-diameter blood vessels (SDBVs). Among potential cell sources, stem cells stand out due to their ability to differentiate into multiple cell types, self-renew, and exhibit low immunogenicity. Additionally, three-dimensionally (3D) printed vascular stents have attracted widespread attention for their precision and controllable bioink application. The need for tissue-engineered blood vessels is currently rising, and innovative design concepts integrating stem cells and 3D printing present promising solutions. Herein, the construction requirements of vascular grafts are reviewed, current status of using stem cells as a cell source and 3D printing as an engineering strategy is described, and prospects and challenges for the development of SDBVs in the medical field are discussed.
心血管疾病已成为全球主要死因。由于冠状动脉、颈动脉和其他血管容易狭窄,小直径人工血管通道为恢复血流提供了关键解决方案。理想的移植物必须模仿天然血管的结构,具备足够的机械强度,确保长期通畅,并包含免疫原性最小的功能细胞。增强细胞来源和工程方法对于创建功能性小直径血管(SDBV)至关重要。在潜在的细胞来源中,干细胞因其能够分化为多种细胞类型、自我更新且免疫原性低而脱颖而出。此外,三维(3D)打印血管支架因其精度和可控的生物墨水应用而受到广泛关注。目前对组织工程血管的需求正在上升,整合干细胞和3D打印的创新设计概念提供了有前景的解决方案。本文综述了血管移植物的构建要求,描述了使用干细胞作为细胞来源和3D打印作为工程策略的现状,并讨论了医学领域SDBV发展的前景和挑战。